Rhythm Biosciences Limited (ASX:RHY)
Australia · Delayed Price · Currency is AUD 0.0970
+0.0050 (5.43%)
Aug 7, 2026, 3:59 PM AEST
Rhythm Biosciences Market Cap
Rhythm Biosciences has a market cap or net worth of 34.33 million as of August 7, 2026. Its market cap has decreased by -10.50% in one year.
Market Cap
34.33M
Enterprise Value
32.86M
Revenue
1.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
ChartMarket Cap Chart
Since December 7, 2017, Rhythm Biosciences's market cap has increased from 32.74M to 34.33M, an increase of 4.83%. That is a compound annual growth rate of 0.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 34.33M | -22.02% |
| Dec 31, 2025 | 44.02M | 78.41% |
| Dec 31, 2024 | 24.67M | -17.35% |
| Dec 29, 2023 | 29.85M | -86.11% |
| Dec 30, 2022 | 215.00M | -33.62% |
| Dec 31, 2021 | 323.86M | 83.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 447.11M |
| Healius | 304.99M |
| Monash IVF Group | 266.90M |
| Cryosite | 58.57M |
| Microba Life Sciences | 34.42M |
| INOVIQ | 27.45M |
| BCAL Diagnostics | 23.96M |
| ImExHS | 17.30M |